AlzeCure Pharma AB (publ) (STO:ALZCUR)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.470
-0.005 (-0.34%)
Apr 10, 2026, 5:09 PM CET
Market Cap169.50M -30.4%
Revenue (ttm)n/a
Net Income-47.65M
EPS-0.47
Shares Out114.91M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume135,113
Average Volume57,791
Open1.505
Previous Close1.475
Day's Range1.440 - 1.505
52-Week Range1.440 - 4.950
Beta0.01
RSI27.89
Earnings DateApr 8, 2026

About AlzeCure Pharma AB

AlzeCure Pharma AB (publ) operates as a pharmaceutical company that develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer’s disease, sleep disorders, depression, traumatic brain injuries, and Parkinson’s disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are i... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 11
Stock Exchange Nasdaq Stockholm
Ticker Symbol ALZCUR
Full Company Profile

Financial Performance

Financial Statements